Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
September 19, 2009
Use of reporter genes to study promoters of the androgen receptor
Lirim Shemshedini
Molecular Endocrinology (Baltimore, Md.)
|
April 15, 2014
COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells
Meenakshi Bhansali, Lirim Shemshedini
Molecular Endocrinology (Baltimore, Md.)
|
December 10, 2015
TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins
Meenakshi Bhansali, Jun Zhou, Lirim Shemshedini
Molecular Cancer Research : MCR
|
July 20, 2007
c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer
Changmeng Cai, Chen-Lin Hsieh, Lirim Shemshedini
Endocrine Oncology (Bristol, England)
|
February 27, 2024
MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer
Prabesh Khatiwada, Ujjwal Rimal, Zhengyang Han, et al.
Plos One
|
November 16, 2013
Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cells
Shuai Gao, Chen-Lin Hsieh, Jun Zhou, et al.
Plos One
|
June 1, 2013
A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer
Shuai Gao, Chen-Lin Hsieh, Meenakshi Bhansali, et al.
Peerj
|
April 17, 2020
Androgen up-regulation of Twist1 gene expression is mediated by ETV1
Prabesh Khatiwada, Archana Kannan, Mamata Malla, et al.
Endocrine Oncology (Bristol, England)
|
October 12, 2023
Peptides disrupting TM4SF3 interaction with AR or AR-V7 block prostate cancer cell proliferation
Prabesh Khatiwada, Ujjwal Rimal, Mamata Malla, et al.
Plos One
|
September 1, 2017
Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells
Jun Zhou, Shuai Gao, Chen-Lin Hsieh, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
September 19, 2009
Use of reporter genes to study promoters of the androgen receptor
Lirim Shemshedini
Molecular Endocrinology (Baltimore, Md.)
|
April 15, 2014
COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells
Meenakshi Bhansali, Lirim Shemshedini
Molecular Endocrinology (Baltimore, Md.)
|
December 10, 2015
TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins
Meenakshi Bhansali, Jun Zhou, Lirim Shemshedini
Molecular Cancer Research : MCR
|
July 20, 2007
c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer
Changmeng Cai, Chen-Lin Hsieh, Lirim Shemshedini
Endocrine Oncology (Bristol, England)
|
February 27, 2024
MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer
Prabesh Khatiwada, Ujjwal Rimal, Zhengyang Han, et al.
Plos One
|
November 16, 2013
Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cells
Shuai Gao, Chen-Lin Hsieh, Jun Zhou, et al.
Plos One
|
June 1, 2013
A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer
Shuai Gao, Chen-Lin Hsieh, Meenakshi Bhansali, et al.
Peerj
|
April 17, 2020
Androgen up-regulation of Twist1 gene expression is mediated by ETV1
Prabesh Khatiwada, Archana Kannan, Mamata Malla, et al.
Endocrine Oncology (Bristol, England)
|
October 12, 2023
Peptides disrupting TM4SF3 interaction with AR or AR-V7 block prostate cancer cell proliferation
Prabesh Khatiwada, Ujjwal Rimal, Mamata Malla, et al.
Plos One
|
September 1, 2017
Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells
Jun Zhou, Shuai Gao, Chen-Lin Hsieh, et al.
Page
of 2